ATE428810T1 - Zellen zum nachweis von influenza- und parainfluenzaviren - Google Patents

Zellen zum nachweis von influenza- und parainfluenzaviren

Info

Publication number
ATE428810T1
ATE428810T1 AT03726367T AT03726367T ATE428810T1 AT E428810 T1 ATE428810 T1 AT E428810T1 AT 03726367 T AT03726367 T AT 03726367T AT 03726367 T AT03726367 T AT 03726367T AT E428810 T1 ATE428810 T1 AT E428810T1
Authority
AT
Austria
Prior art keywords
influenza
parainfluenza
viruses
cells
production
Prior art date
Application number
AT03726367T
Other languages
German (de)
English (en)
Inventor
Yung Huang
Original Assignee
Univ Cleveland Hospitals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cleveland Hospitals filed Critical Univ Cleveland Hospitals
Application granted granted Critical
Publication of ATE428810T1 publication Critical patent/ATE428810T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6454Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT03726367T 2002-04-25 2003-04-17 Zellen zum nachweis von influenza- und parainfluenzaviren ATE428810T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/133,910 US6610474B1 (en) 2002-04-25 2002-04-25 Cells for detection of influenza and parainfluenza viruses
PCT/US2003/012203 WO2003091459A1 (en) 2002-04-25 2003-04-17 Cells for detection of influenza and parainfluenza viruses

Publications (1)

Publication Number Publication Date
ATE428810T1 true ATE428810T1 (de) 2009-05-15

Family

ID=27754313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03726367T ATE428810T1 (de) 2002-04-25 2003-04-17 Zellen zum nachweis von influenza- und parainfluenzaviren

Country Status (8)

Country Link
US (3) US6610474B1 (https=)
EP (1) EP1497468B1 (https=)
JP (1) JP2005523709A (https=)
AT (1) ATE428810T1 (https=)
AU (1) AU2003228607B2 (https=)
CA (1) CA2483747A1 (https=)
DE (1) DE60327190D1 (https=)
WO (1) WO2003091459A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610474B1 (en) * 2002-04-25 2003-08-26 University Hospitals Of Cleveland Cells for detection of influenza and parainfluenza viruses
US7150965B2 (en) * 2003-04-17 2006-12-19 University Hospitals Of Cleveland Cells for detection of influenza and parainfluenza viruses
US20100233674A1 (en) * 2002-04-25 2010-09-16 University Hospitals Of Cleveland Cells for detection and production of influenza and parainfluenza viruses
US7129042B2 (en) * 2003-11-03 2006-10-31 Diagnostic Hybrids, Inc. Compositions and methods for detecting severe acute respiratory syndrome coronavirus
US8318423B2 (en) 2004-07-06 2012-11-27 Focus Diagnostics, Inc. Methods and compositions for detecting rhinoviruses
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
AU2008293504B2 (en) 2007-08-27 2012-04-12 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CA2861667C (en) 2007-10-01 2017-06-13 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system and methods of use
RU2547587C2 (ru) 2008-09-24 2015-04-10 Медиммун, Ллк Способы культивирования клеток, размножения и очистки вирусов
US8376955B2 (en) * 2009-09-29 2013-02-19 Covidien Lp Spectroscopic method and system for assessing tissue temperature
WO2013112916A1 (en) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
WO2016183292A1 (en) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
EP3249406A1 (de) * 2016-05-27 2017-11-29 PerkinElmer Cellular Technologies Germany GmbH Verfahren zur bestimmung der anzahl von infektionsherden einer zellkultur
EP4036209A1 (en) * 2021-01-29 2022-08-03 Leica Microsystems CMS GmbH Microplate for containing a plurality of samples
CN115015549B (zh) * 2022-07-14 2023-01-13 深圳市卫光生物制品股份有限公司 一种狂犬病疫苗灭活验证的试验方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939253A (en) 1996-04-26 1999-08-17 Diagnostic Hybrids, Inc. Compositions and methods for detecting viral infection
US20020082224A1 (en) * 1997-01-14 2002-06-27 Douglas J. Jolly Non-immunogenic prodrugs and selectable markers for use in gene therapy
US6168915B1 (en) 1998-04-24 2001-01-02 Diagnostic Hybrids, Inc. Mixed cell diagnostic systems
US6610474B1 (en) * 2002-04-25 2003-08-26 University Hospitals Of Cleveland Cells for detection of influenza and parainfluenza viruses

Also Published As

Publication number Publication date
DE60327190D1 (de) 2009-05-28
CA2483747A1 (en) 2003-11-06
AU2003228607A1 (en) 2003-11-10
WO2003091459A1 (en) 2003-11-06
US20030203357A1 (en) 2003-10-30
JP2005523709A (ja) 2005-08-11
US6991899B2 (en) 2006-01-31
US20040234947A1 (en) 2004-11-25
EP1497468A4 (en) 2005-09-14
US6610474B1 (en) 2003-08-26
AU2003228607B2 (en) 2006-08-24
EP1497468B1 (en) 2009-04-15
EP1497468A1 (en) 2005-01-19

Similar Documents

Publication Publication Date Title
ATE428810T1 (de) Zellen zum nachweis von influenza- und parainfluenzaviren
Hasebe et al. Combined detection and genotyping of Chikungunya virus by a specific reverse transcription‐polymerase chain reaction
DE50214416D1 (de) Vermehrung von viren in zellkultur
EA200900784A1 (ru) Вакцины, включающие антиген из четырех штаммов вируса гриппа
Setz et al. Inhibitors of deubiquitinating enzymes block HIV-1 replication and augment the presentation of gag-derived MHC-I epitopes
Li et al. An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions
Chen et al. Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors
Kishor et al. Introduction to covid-19
Li et al. Molecular epidemiology of the heterosexual HIV-1 transmission in Kunming, Yunnan Province of China suggests origin from the local IDU epidemic
Potiwat et al. Competitive suppression between chikungunya and dengue virus in Aedes albopictus c6/36 cell line
Orloff et al. V3 loops of HIV-1 specimens from pregnant women in Malawi uniformly lack a potential N-linked glycosylation site
Ren et al. Characterization of SARS-CoV-2 variants B. 1.617. 1 (Kappa), B. 1.617. 2 (Delta) and B. 1.618 on cell entry, host range, and sensitivity to convalescent plasma and ACE2 decoy receptor
Boon et al. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity
Tsuchie et al. HIV-1 variants in south and south-east Asia
CN101487061A (zh) A型流感病毒流行毒株检测和分型基因芯片及使用方法
Hassan et al. The incidence of HIV among blood donors in Kaduna, Nigeria
CY1110861T1 (el) Μορια νουκλεϊνικων οξεων toy hdv, θραυσματα αυτων και εφαρμογες αυτων
WO2008079298A3 (en) Cells for detection and production of influenza and parainfluenza viruses
ES2057579T3 (es) Peptidos e1 y c de rubeola.
CN1468955A (zh) 一种新型冠状病毒
RU2703024C1 (ru) Штамм вируса гриппа B/Novosibirsk/40/2017-MA для изучения лечебной и профилактической эффективности противовирусных препаратов in vitro и in vivo
HUP0302416A2 (hu) Tisztított hepatitis-C vírusmembrán-proteinek diagnosztikai és terápiás célú alkalmazása
CN1231763C (zh) 艾滋病病毒快速检测试纸的制备及使用方法
Inoshima et al. Cross virus neutralizing antibodies against feline immunodeficiency virus genotypes A, B, C, D and E
Verma et al. Insights into molecular evolution and increased transmissibility of SARS-CoV-2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties